These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9436745)

  • 1. Risperidone in levodopa induced dyskinesiae.
    Meco G; Fabrizio E; Alessandri A; Vanacore N; Bonifati V
    J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):135. PubMed ID: 9436745
    [No Abstract]   [Full Text] [Related]  

  • 2. Risperidone treatment of tardive dyskinesia and dystonia.
    Chong SA; Remington G; Tan CH
    J Clin Psychiatry; 1999 May; 60(5):340-1. PubMed ID: 10362448
    [No Abstract]   [Full Text] [Related]  

  • 3. The NMDA antagonist budipine can alleviate levodopa-induced motor fluctuations.
    Spieker S; Löschmann PA; Klockgether T
    Mov Disord; 1999 May; 14(3):517-9. PubMed ID: 10348483
    [No Abstract]   [Full Text] [Related]  

  • 4. Rating scales for dyskinesias in Parkinson's disease.
    Goetz CG
    Mov Disord; 1999; 14 Suppl 1():48-53. PubMed ID: 10493403
    [No Abstract]   [Full Text] [Related]  

  • 5. [Medical treatment of L-dopa induced dyskinesia].
    Kuno S
    Nihon Rinsho; 2000 Oct; 58(10):2110-4. PubMed ID: 11068456
    [No Abstract]   [Full Text] [Related]  

  • 6. [Physiopathology of the dyskinesias induced by L-dopa].
    Grandas F; López-Ariztegui N
    Rev Neurol; 1997 Aug; 25 Suppl 2():S151-6. PubMed ID: 9280682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug treatments of levodopa-induced dyskinesias.
    Vale S
    Lancet; 1999 Aug; 354(9177):511. PubMed ID: 10465195
    [No Abstract]   [Full Text] [Related]  

  • 8. Riluzole for levodopa-induced dyskinesias in advanced Parkinson's disease.
    Merims D; Ziv I; Djaldetti R; Melamed E
    Lancet; 1999 May; 353(9166):1764-5. PubMed ID: 10347995
    [No Abstract]   [Full Text] [Related]  

  • 9. [Risperidone].
    Zolk O; Thürauf N
    Dtsch Med Wochenschr; 2003 Jun; 128(24):1353-6. PubMed ID: 12802745
    [No Abstract]   [Full Text] [Related]  

  • 10. Levetiracetam in L-dopa-induced dyskinesia.
    Meco G; Fabrizio E; Epifanio A; Di Raimondo G; Vanacore N; Morgante L
    Clin Neuropharmacol; 2005; 28(2):102-3. PubMed ID: 15795556
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible role for chlorpheniramine in the treatment of L-DOPA induced dyskinesia in Parkinson's disease.
    Karamanakos PN; Pappas P; Marselos M
    Pharm World Sci; 2008 Jan; 30(1):1-2. PubMed ID: 17597418
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative assessment of dyskinesias in subhuman primates.
    Brotchie JM; Fox SH
    Mov Disord; 1999; 14 Suppl 1():40-7. PubMed ID: 10493402
    [No Abstract]   [Full Text] [Related]  

  • 13. Sudden appearance of invalidating dyskinesia-dystonia and off fluctuations after the introduction of levodopa in two dopaminomimetic drug naive patients with stage IV Parkinson's disease.
    Onofrj M; Paci C; Thomas A
    J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):605-6. PubMed ID: 9771801
    [No Abstract]   [Full Text] [Related]  

  • 14. Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations.
    Furukawa Y; Filiano JJ; Kish SJ
    Mov Disord; 2004 Oct; 19(10):1256-8. PubMed ID: 15389992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological mechanisms of the treatment of dyskinesias in Parkinson disease].
    Jiménez-Jiménez FJ; Molina JA; Ortí-Pareja M
    Rev Neurol; 1999 May 1-15; 28(9):889-98. PubMed ID: 10390756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unified dyskinesias rating scale for L-dopa-induced dyskinesias?
    Nutt J
    Mov Disord; 1999; 14 Suppl 1():74. PubMed ID: 10493408
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of levetiracetam on levodopa induced dyskinesia in patients with Parkinson's disease.
    Tousi B; Subramanian T
    Parkinsonism Relat Disord; 2005 Aug; 11(5):333-4. PubMed ID: 15949966
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3).
    Oertel W; Eggert K; Pahwa R; Tanner CM; Hauser RA; Trenkwalder C; Ehret R; Azulay JP; Isaacson S; Felt L; Stempien MJ
    Mov Disord; 2017 Dec; 32(12):1701-1709. PubMed ID: 28833562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New use for an old drug: amantadine benefits levodopa-induced dyskinesia.
    Rajput AH; Rajput A; Lang AE; Kumar R; Uitti RJ; Galvez-Jimenez N
    Mov Disord; 1998 Sep; 13(5):851. PubMed ID: 9756161
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of levodopa-induced dyskinesias with donepezil.
    Caroff SN; Martine R; Kleiner-Fisman G; Eisa M; Lorry A; Gallop R; Stern MB; Duda JE
    Parkinsonism Relat Disord; 2006 May; 12(4):261-3. PubMed ID: 16364675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.